Ring transformation of 6H-cyclopropa[e]pyrazolo[1,5-a]pyrimidine. IV (1). Reduction and reaction of 5a-acetyl-6a-ethoxycarbonyl-5a,6a-dihydro-6H-cyclopropa[e]pyrazolo[1,5-a]pyrimidine-3-carbonitriles with primary amines

The reaction of 5a-acetyl-6-ethoxycarbonyl-5a,6a-dihydro-6H-cyclopropa[e]pyrazolo[1,5-a]pyrimidine-3-carbonitrile ( 1a ) with benzylamine gave ethyl l-benzyl-5-cyano-8a,9-dihydro-2-methyl-1H-pyrrolo[3,4-e]-pyrazolo[1,5-a]pyrimidine-8a-carboxylate ( 2a ), in addition to 5-acetyl-3-benzylamino-1-(4-cyanopyrazol-3-yl)- 2-pyridone ( 3 ). Reaction of 1a with aniline gave ethyl 6-acetyl-8-anilino-3-cyano-7,8-dihydro-4H-pyrazolo-[1,5-a][1,3]diazepine-8-carboxylate ( 4 ), in addition to ethyl 3-cyano-7-methyl-6-pyrazolo[1,5-a]pyrimidine-acrylate ( 5 ). On the other hand, the same reactions of 1b with benzylamine or aniline gave 2b or 8b , respectively. Though catalytic hydrogenation of 1a over 5% palladium-carbon proceeded by ring fission of cyclopropane ring to give 9 , 1a (or 1b ) afforded 4,5-dihydro derivatives ( 13 or 15 ) by catalytic hydrogenation over platinum oxide. The reactivity of 5-methoxy-4,5,5a,6a-tetrahydro-6H-cyclopropa[e]pyrazolo[1,5-a]pyrimidine ( 16 ), which are related analogs of 1a,b , is also described.     

Cyclization mechanism for the synthesis of macrocyclic antibiotic lankacidin in Streptomyces rochei

The lankacidin biosynthetic gene cluster in Streptomyces rochei strain 7434AN4 was found to span 31 kb of the giant linear plasmid pSLA2-L and contain a polyketide synthase (PKS)/nonribosomal peptide synthetase (NRPS) hybrid gene (lkcA), type I PKS genes, and pyrroloquinoline quinone (PQQ) biosynthetic genes (lkcK-lkcO). Feeding of PQQ to a pqq mutant restored the lankacidin production, suggesting its crucial role in an oxidation process. However, formation of the 17-membered macrocyclic ring was not catalyzed by PQQ-dependent dehydrogenase (Orf23), but was by flavin-dependent amine oxidase (LkcE). Compound LC-KA05 isolated from an lkcE disruptant was an acyclic intermediate lacking the C2-C18 linkage. These results suggested a cyclization mechanism for the synthesis of the lankacidin macrocyclic skeleton.     

The molecular structure and chemical reactivities of the condensation products of o-substituted benzylidenacetylacetone with hydrazine dihydrochloride

Reaction of o-nitrobenzylideneacetylacetone ( 1a ) with hydrazine dihydrochloride in methanol gave 4-(α-methoxy-o-nitrobenzyl)-3,5-dimethylpyrazole hydrochloride ( 4a ), whose structure was unambigously confirmed by an X-ray crystallographic analysis, via 4-(o-nitrobenzylidene)-3,5-dimethylisopyrazole ( 2a ). Compound 2a was synthesized by condensation of 1a with hydrazine dihydrochloride in acetonitrile. Analogously the corresponding o-chloro derivatives ( 2b, 4b ) were obtained. These were converted to N-methyl ( 6b ) and N-acetyl ( 7a,b ) derivatives and the behaviors on bromination and pyrolysis were investigated.     

A study of the alumina-silica gel adsorbent for the removal of silicic acid from geothermal water: increase in adsorption capacity of the adsorbent due to formation of amorphous aluminosilicate by adsorption of silicic acid

Two kinds of adsorbents (Si adsorbent and Al adsorbent) for the removal of silicic acid from geothermal water to retard the formation of silica scales were prepared using silicic acid contained in geothermal water. The Si adsorbent was prepared by evaporating geothermal water, and the Al adsorbent was prepared by evaporating geothermal water after the addition of aluminum chloride. The specific surface area of the Si adsorbent was small and it's adsorption capacity of silicic acid was low. Although the specific surface area of the Al adsorbent was also small, it was significantly increased by the adsorption of silicic acid and it's adsorption capacity was high. Based on the change in the local structure of aluminum ion by the adsorption of silicic acid, the Al adsorbent was considered to be silica particles covered with crystalline aluminum hydroxide. Moreover, it was concluded that the increase in the specific surface area of the Al adsorbent and the decrease in the zeta potential were due to the formation of an amorphous aluminosilicate with a large surface area and a negative charge (one 4-coordinated Al) by the reaction between aluminum ions and silicic acids.     

Alignment behaviour of the discotic nematic phase of 2,3,6,7,10,11-hexa(4-n-octyloxybenzoyloxy)triphenylene on polyimide and cetyltrimethylammonium bromide coated substrates

The orientational behaviour of the nematic discotic phase of 2,3,6,7,10,11-hexa(4-n-octyloxybenzoyloxy)triphenylene (C8OBT) on substrates coated with a polyimide or cetyltrimethylammonium bromide (CTAB) was investigated by polarizing optical microscopy. The averaged order parameters and directions of the triphenylene core and the carbonyl groups of C8OBT were evaluated by an infrared dichroic method. The discotic nematic (N_D) phase of C8OBT exhibits a homeotropic alignment on a polyimide film, a typical nematic schlieren texture on a glass substrate, and a tilted or planar homogeneous alignment on a CTAB-coated substrate. The order parameter of the triphenylene core is higher on a polyimide film (S = 0.6) than on a CTAB-coated substrate (S = 0.2), whereas that of the carbonyl groups remains roughly constant at 0.2 to 0.3 independent of the substrate for the N_D phase.     

Water inclusion as a trigger for modulation of anthracene arrangement and fluorescence emission of organic salt

An organic salt composed 9,10-bis(4-aminophenyl)anthracene and hypophosphorous acid emits yellow-green fluorescence in the crystalline state. The salt also gives water inclusion crystal which provides blue-green fluorescence. Single X-ray crystal studies revealed that water molecules induced the fluorescence change resulting from reaggregation of molecular packing.     

Rational Design and Identification of a Non‐Peptidic Aggregation Inhibitor of Amyloid‐β Based on a Pharmacophore Motif Obtained from cyclo[‐Lys‐Leu‐Val‐Phe‐Phe‐]

Inhibition of pathogenic protein aggregation may be an important and straightforward therapeutic strategy for curing amyloid diseases. Small‐molecule aggregation inhibitors of Alzheimer’s amyloid‐β (Aβ) are extremely scarce, however, and are mainly restricted to dye‐ and polyphenol‐type compounds that lack drug‐likeness. Based on the structure‐activity relationship of cyclic Aβ16–20 (cyclo‐[KLVFF]), we identified unique pharmacophore motifs comprising side‐chains of Leu², Val³, Phe⁴, and Phe⁵ residues without involvement of the backbone amide bonds to inhibit Aβ aggregation. This finding allowed us to design non‐peptidic, small‐molecule aggregation inhibitors that possess potent activity. These molecules are the first successful non‐peptidic, small‐molecule aggregation inhibitors of amyloids based on rational molecular design.